Skip to main content
Equibles
IRIX logo

IRIX · Iridex Corp · Metrics

Track IRIX — free

Use IRIX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IRIX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.75 -0.02 (-2.18%)
Rebalance outlook locked
Market Cap
$13.39M
Shares
17.56M
Volume · Oct 23 18.98K Avg daily vol (3M) 390.46K

IRIX metrics

86 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.75
Market cap
$13.39M

Price action

20 metrics
Price change (1W)
-7.5%
Price change (30D)
+20.0%
Price change (3M)
-17.1%
Price change (6M)
-27.4%
Price change (YTD)
-33.1%
Price change (1Y)
-28.1%
Trailing year
Price change (5Y)
-89.9%
52-week high
$1.56
52-week low
$0.61
Change from 52-week high
-51.1%
Change from 52-week low
+25.0%
Annualized volatility
73.2%
Annualized volatility (3M)
80.6%
Beta
0.8
RSI (14D)
50.4
Price vs SMA 50
+4.4%
Price vs SMA 200
-27.8%
Avg volume (3M)
390,575
Relative volume
0.0
Average dollar volume
$335,786

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
17.56M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 382.5%
P / book
3.7
reciprocal yield 27.0%
FCF yield
-14.8%
TTM · current market cap
Buyback yield
0.4%
P / FCF
—
P / operating cash flow
—
Earnings yield
-26.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.4×
reciprocal yield 253.6%
EV / revenue historical average (5Y)
0.8×
reciprocal yield 126.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-18

Profitability

9 metrics
Gross margin
35.9%
Operating margin
-5.4%
Trailing 12 months
Net margin
-6.9%
Gross profit (TTM)
$18.53M
Operating profit (TTM)
−$2.78M
Net income (TTM)
−$3.55M
Trailing 12 months
Diluted EPS (TTM)
$-0.20
FCF margin
-3.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$2.99
Gross profit per diluted share (TTM)
$1.08
Operating profit per diluted share (TTM)
$-0.16
EBITDA per diluted share (TTM)
$-0.14
Net income per diluted share (TTM)
$-0.21
Operating cash flow per diluted share (TTM)
$-0.10
Free cash flow per diluted share (TTM)
$-0.12
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
$0.22
Stock compensation per diluted share (TTM)
$0.10
Book value per share
$0.28

Growth

11 metrics
Revenue growth YoY
-7.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$51.57M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.7%
Year over year · more shares
Revenue CAGR (3Y)
-2.6%
Revenue CAGR (5Y)
+7.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-97.5%
Return on assets
-13.0%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
−$2.33M
Free cash flow (TTM)
−$2.00M
Quick ratio
1.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$4.68M
Total assets
$27.26M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$1.73M
Capital expenditures (TTM)
$270,000
R&D (TTM)
$3.76M
SG&A (TTM)
—
Stock compensation (TTM)
$1.06M
R&D / revenue
7.3%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
29
13F filer change QoQ
+4
Institutional ownership
12.4%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
4.5%
Private-fund adviser ownership
4.3%
Active holders' share change QoQ
-1.1%
Holder tenure
10.6
Price vs estimated holder cost
-32.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
3.7%

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
41 / 100

Insider activity

2 metrics
Net insider buying (90D)
$14,974
Insider-sentiment score
80 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1006045 CUSIP 462684101 13F (30d) 4 filings 4 filers Visit website Investor relations